Dr Irmgard Irminger-Finger – Chief Scientific Officer/Executive Director PD, PhD (appointed 16 June 2016)
Melbourne, Australia, 15 January 2021: BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company) announces that Dr Irmgard Irminger-Finger has stepped down from the board. Dr IrmingerFinger, who resides in Geneva, Switzerland
sure... they were going to get the lung test to be a success in the next 5 months after 5 years of failure and changing their focus to other technology, including a merger with new tech, which caused the share price to go nuts
Ann: Commencement of Legal Proceedings Against BARD1, page-46
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.020(4.00%) |
Mkt cap ! $53.53M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 50.0¢ | 47.5¢ | $51.53K | 106.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11170 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 10000 | 2 |
View Market Depth
| Last trade - 11.55am 01/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |